Cancer & Oncology News Articles, Viewpoints & Features

Viewpoints

Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings.

On-Body Injections of Pegfilgrastim May Not Always Be Preferred — But They’re On Schedule

By

November 4, 2020

Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings.

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.

American Cancer Society Updates Cervical Cancer Screening Guidelines

By

Victoria Forster, PhD

September 16, 2020

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.

From the Advisory Board

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

By

Isabel Cunningham, MD

September 3, 2015

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Slideshows

BAVENCIO (avelumab) for Merkel Cell Carcinoma

IMLYGIC (talimogene laherparepvec) for Melanoma

Features

Throughout the COVID-19 pandemic, clinicians who care for patients with lung cancer have made multiple treatment approach changes for this vulnerable population.

Navigating Disruptions to Lung Cancer Treatment During the COVID-19 Pandemic

By

Katarina Zimmer, MSci, MS

April 22, 2021

Throughout the COVID-19 pandemic, clinicians who care for patients with lung cancer have made multiple treatment approach changes for this vulnerable population.

A workshop was convened by the US Food and Drug Administration and the American Association for Cancer Research to create recommendations for trial design and later stages of drug development in multiple myeloma.

Recommendations From FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials

By

Carina Storrs, PhD

April 9, 2021

A workshop was convened by the US Food and Drug Administration and the American Association for Cancer Research to create recommendations for trial design and later stages of drug development in multiple myeloma.

Socioeconomics Tied to Cognitive Function in Survivors of Childhood Brain Tumors

By

Victoria Forster, PhD

April 8, 2021

Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.

Features

Viewpoints

On-Body Injections of Pegfilgrastim May Not Always Be Preferred — But They’re On Schedule

American Cancer Society Updates Cervical Cancer Screening Guidelines

From the Advisory Board

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

Slideshows

BAVENCIO (avelumab) for Merkel Cell Carcinoma

IMLYGIC (talimogene laherparepvec) for Melanoma

Features

Navigating Disruptions to Lung Cancer Treatment During the COVID-19 Pandemic

Recommendations From FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials

Socioeconomics Tied to Cognitive Function in Survivors of Childhood Brain Tumors

Want to read more?

Case Study: Sexual Dysfunction Evaluation After Breast Cancer at an Oncology Sexual Health Clinic